Adjuvant, as an important part of vaccines, can observably enhance the magnitude, breadth
and durability of immune responses. Nanoadjuvants, as novel vaccine adjuvants, have …

The concept of integrating immunogenic cell death (ICD) with tailoring the
immunosuppressive tumor microenvironment (TME) is promising for immunotherapy …

Nanomaterials-based phototherapies, mainly including photothermal therapy (PTT),
photodynamic therapy (PDT) and photoimmunotherapy (PIT), present high efficacy, minimal …

Due to the specific tumor microenvironment (TME) and immunosuppressive state of cancer
cells, conventional antitumor therapies face severe challenges, such as high rates of …

A series of biological barriers in a nanoparticle-formulated drug delivery process inevitably
result in the current low delivery efficiency, limited tumor penetration and insufficient cellular …

A series of barriers including poor drug solubility, stability, biocompatibility, bioavailability
and pharmacokinetics, distribution to normal tissues, hemorheological flow limitations …

Background Magnetic hyperthermia (MHT)-mediated thermal ablation therapy has
promising clinical applications in destroying primary tumours. However, traditional MHT still …

Immunostimulatory agents, including adjuvants, cytokines, and monoclonal antibodies, hold
great potential for the treatment of cancer. However, their direct administration often results …

Enriching the application of multifunctional dendritic mesoporous organosilica (DMOS) is
still challenging in anti‐cancer research. Herein, manganese ions, iron ions, or cobalt ions …

Immunotherapy has made great strides in improving clinical outcomes in cancer treatment.
However, few patients exhibit adequate response rates for key outcome measures and …